A randomized, double-blind, placebo-controlled trial by Cho et al. (2014) in 76 men showed a 40% increase in hair count at 24 weeks compared to 10% in placebo. A comprehensive review by Evron et al. (2020) confirmed saw palmetto produces positive hair growth outcomes in 60% of patients without sexual adverse effects.
Saw Palmetto & Pumpkin Seed Sterols
Lipid-sterol botanical complex delivering dual 5α-reductase inhibition to lower follicular DHT without systemic sexual side effects.
A randomized, double-blind, placebo-controlled trial by Cho et al. (2014) in 76 men showed a 40% increase in hair count at 24 weeks compared to 10% in placebo. A comprehensive review by Evron et al. (2020) confirmed saw palmetto produces positive hair growth outcomes in 60% of patients without sexual adverse effects.
Long-term multi-cohort replication and optimal individualization remain active areas of study.
Effect of Pumpkin Seed Oil on Hair Growth in Men with Androgenetic Alopecia
“Target Hair Count Increase: +40%”
Safety Boundary & Dosing Considerations
“Individual variation in bioavailability and optimal dosing thresholds.”
Scientific Dual-Coverage Profile
Standardized evaluation across 8 Systemic Longevity Vectors and 12 Hallmarks of Aging.
Heart & Cardiovascular
Synergistic Target (30-64)Plant sterols mildly compete with dietary cholesterol absorption in the small intestine.
Brain Longevity & Cognition
Neutral PathwayNo direct central neuromodulatory or cognitive enhancing activity.
Metabolic & Glycemic Health
Synergistic Target (30-64)Provides linoleic and oleic fatty acids supporting cell membrane fluidity.
Cancer Defense & Autophagy
Synergistic Target (30-64)Reduces excessive intraprostatic DHT accumulation, preventing benign and pre-malignant hyperplastic proliferation.
Endocrine Vitality & Anabolic Tone
Foundational Target (65-100)Liposterolic phytosterols inhibit both Type I and Type II 5α-reductase, preventing testosterone conversion to tissue DHT without altering circulating serum testosterone or LH.
Systemic Inflammation Suppression
Foundational Target (65-100)Beta-sitosterol downregulates 5-lipoxygenase (5-LOX) and cyclooxygenase-2 (COX-2) pathways.
Bone Density & Connective Matrix
Neutral PathwayNo direct osteoblast mechanotransduction or bone mineral deposition.
Cellular Longevity & Epigenetics
Foundational Target (65-100)Rescues miniaturized hair follicle bulb cells from androgen-mediated catagen entry, sustaining robust protein synthesis in active anagen.
Functional Outcomes & Performance Impact
Calibrated clinical effect sizes (0–99 scale) for practical daily goals beyond pure longevity — including physical strength, cognitive focus, restorative sleep, and metabolic resilience.
Phytosterol 5α-Reductase Modulation
Clinical Endpoint: Double-blind RCT showed +40% increase in hair count via dual 5α-reductase inhibition without altering testosterone.
Score Breakdown: 88 / 100
Study design hierarchy (RCT > Cohort > Rodent > In Vitro), journal impact factor, sample power.
Shift in clinically validated biomarkers (VO2 Max, ApoB, Fasting Insulin, hs-CRP, Epigenetic Clocks).
Adverse event frequency, toxicology window, long-term organ tolerability.
Multi-system pleiotropy across the 8 canonical longevity vectors.
Affordability, time burden, friction to sustained daily/weekly compliance.
Practicality, Cost & Adherence Index
Saw Palmetto & Pumpkin Seed Sterols Multi-Trial Scientific Evidence
Transparent catalog of peer-reviewed human clinical trials and landmark animal cohorts with exact biomarker deltas, sample sizes, and risk-of-bias evaluations.
Saw Palmetto & Pumpkin Seed Sterols Evidence Timeline
Initial Mechanistic Validation
Early molecular characterization demonstrates direct modulation of cellular stress pathways.
Controlled Human Pilot Trial
Demonstrated statistically significant shifts in primary biomarkers without dose-limiting adverse events.
Saw Palmetto & Pumpkin Seed Sterols Safety Matrix
Absolute Contraindications (Do Not Use)
- •Pregnancy or nursing (anti-androgenic activity)
- •Known hypersensitivity to saw palmetto or cucurbits
Pharmacological & Supplement Interactions
No high-risk pharmacokinetic interactions documented.
Proven Adverse Effects vs. Theoretical Risks
- Transient and mild when used at therapeutic doses.
Under-Researched Populations (Evidence Gaps)
Clinical longevity literature disproportionately studies middle-aged male or rodent models. Exercise caution in:
- Premenopausal women
- Pediatric cohorts
Biological Relationship Graph
Combines safely with baseline longevity routines.
No direct clinical antagonisms detected.